drugset / Trial / NCT02256735
Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to investigate the effect of Ritobegron CL (KUC 7483 CL) on the QT/QTc interval of the ECG in comparison to placebo and moxifloxacin
Timeline
- Start
- 2005-08
- Primary completion
- 2005-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | — | — |
| Subject | Ritobegron | Small molecule | 40 mg | Oral |
| Subject | Ritobegron | Small molecule | 80 mg | Oral |
| Subject | Ritobegron | Small molecule | 160 mg | Oral |
| Subject | Ritobegron | Small molecule | 320 mg | Oral |
Indications
No indication recorded.